News

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK. The £6 million project results in a state-of-the-art drug substance manufacturing capability that can deliver integrated support for customers from candidate selection through to early clinical development and beyond.

Oxilio announces start of its first clinical trial with OXL001

Oxilio has commenced first human subject dosing of OXL001. The product leverages the Quotient Sciences Translational Pharmaceutics® platform for drug development.

Emplicure AB Announce Completion of Phase I PK study for EMPLI03 with Quotient Sciences

Emplicure AB reported dosing in the first Phase I pharmacokinetic study for EMPLI03, intended for the treatment of moderate to severe pain. The program is supported by Quotient Sciences Translational Pharmaceutics® platform.

Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

Oxilio and Quotient Sciences announced an update on the development of Oxilio’s OXL001 product, which uses Quotient Sciences’ Translational Pharmaceutics® platform.

Quotient Sciences Completes Qualification of GastroPlus® PBPK Modeling Software

Quotient Sciences’ Modeling and Simulation (M&S) team has recently completed qualification of GastroPlus software for physiologically based pharmacokinetic (PBPK) modeling.

Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs

Quotient Sciences has completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs.

Thought Leadership

Gareth Jenkins Contributes to Chemistry Today Panel Discussion on Flow Chemistry

Gareth Jenkins, VP Science and Technology, Candidate Development Services at Quotient Sciences, Contributes to Chemistry Today Panel Discussion on Flow Chemistry. Read it here.